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Abstract
In this paper, we consider estimation of the effect of a randomized treatment on
time to disease progression and death, possibly adjusting for high-dimensional baseline
prognostic factors. We assume that patients may or may not have a specific type of
disease progression prior to death and those who have this endpoint are followed for
their survival information. Progression and survival may also be censored due to loss to
follow-up or study termination. We posit a semi-parametric bivariate quantile-quantile
regression failure time model and show how to construct estimators of the regression
parameters. The causal interpretation of the parameters depends on non-identifiable
assumptions. We discuss two assumptions: the first applies to situations where it is
reasonable to view disease progression as well defined after death and the second applies
to situations where such a view is unreasonable. We conduct a simulation study and
analyze data from a randomized trial for the treatment of brain cancer.
KEYWORDS: Brain Tumors; Causal Inference; Censoring by Death; Estimating Equa-
tions
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1 Introduction
In randomized trials to evaluate treatment of life-threatening diseases, subjects are often
monitored for specific types of disease progression and survival. In such studies, a progres-
sion endpoint may be pre-empted by death or censored due to loss to follow-up or study
termination. Subjects who experience a progression event are also followed for survival,
which may be censored. Data of this form has been labeled semi-competing risks data (Fine,
Jiang, and Chappell, 2001). Our motivating example of a study which produces such data
is a randomized trial for the treatment of malignant brain tumors. In the study, one of the
important progression endpoints was based on deterioration, from baseline, of the cerebel-
lum. An important feature of this endpoint is that it is biologically plasuible that a subject
could die without cerebellar deterioration.
Robins (1995a, 1995b) and Lin et al. (1996) introduced a semi-parametric bivariate
location-shift model to describe the joint effect of treatment on progression and survival
in two-arm randomized studies. This model can be viewed as a bivariate linear regression
with log of the survival and progression endpoints as the response, correlated error terms,
and treatment indicator as the sole covariate. The regression parameter for survival is
estimated using the estimating function technique of Louis (1981), Wei and Gail (1983) and
Tsiatis (1990). Working on the residual death time scale, the estimating function is based
on the comparison of the observed treatment indicator at each death time to the expected
value of the treatment indicator among subjects at risk at that time. Lin et al. (1996)
noticed that application of this technique to the progression endpoint leads to a biased
estimating function because (1) progression can be pre-empted by death and (2) death and
progression are correlated events. To solve this problem, Lin et al. (1996) used an idea
originally introduced by Robins and Rotnitzky (1992, Appendix 4) and corrected the bias
of the estimating function by artificially censoring the progression residuals. This approach
works well for a low-dimensional covariate, such as a treatment indicator, but excessive
artificial censoring can occur when the covariates are high-dimensional. To address this
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latter problem, Peng and Fine (2006) introduced a new artificial censoring technique based
on pairwise ranking. While this technique represents an improvement over the approach
of Lin et al. (1996), it can, contrary to the suggestion of those authors, be less efficient
than the alternative method introduced in this paper. There has been increased use and
extension of the bivariate linear regression model in the analysis of recurrent event data and
repeated measures data subject to informative drop-out (see, for example, Chang (2000),
Joffe (2001), Ghosh and Lin (2003), Lin and Ying (2003), and Matsui (2004)). All these
approaches use the artificial censoring technique of Lin et al. (1996) and, as a result, have
difficulty dealing with high-dimensional covariates. In this paper, we introduce an alternative
estimating equation that does not rely on the artificial censoring technique.
The paper is organized as follows. In Section 2, we introduce the study that motivated
this research. In Section 3, we introduce the data structure, notation, and the generalized
bivariate quantile-quantile regression model and its special case the bivariate linear regres-
sion model. Section 4 discusses issues of identifiability and Section 5 discusses the causal
interpretation of the treatment effect regression parameters. Section 6 is devoted to estima-
tion, while Section 7 discusses large sample theory. In Section 8, we present the results of
a simulation study and Section 9 provides an analysis of the brain tumor trial. The final
section is devoted to a discussion. To ease the flow of presentation, proofs of lemmas and
theorems are placed in the Appendix. For readers who are less concerned with technical
details, Section 7 and the Appendix can be skipped without loss of continuity.
2 Brain Tumor Study
2.1 Gliomas
Gliomas are primary brain tumors. Treatment for glioma involves maximal surgical resection
of the tumor, followed by radiotherapy and chemotherapy. Prior to 1990, adjuvantchemother-
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apy for brain tumors was limited because of the difficulty in achieving adequate exposure
to the tumor site without causing systemic toxicity. In a phase 1 study, Brem et al. (1991)
showed this diificulty could be overcome by implanting at surgery local to the tumor, a
biodegradable polymers impreganted with the drug carmustine (BCNU), resulting in pro-
longed local exposure to BCNU with minimal systemic exposure.
2.2 Glioma Trial
The Phase I study was followed by a randomized trial, in which 222 patients with recurrent
malignant brain tumors scheduled for tumor resection were randomly assigned to receive
surgically implanted biodegradable polymer discs with or without 3.85% of carmustine (Brem
et al. 1995). Patients were included in the study if they had a single focus of tumor in
the cerebrum, a Karnofsky score greater than 60, completed radiation therapy, not taken
nitrosoureas within 6 weeks of enrollment, and did not have systemic chemotherapy within
4 weeks of enrollment.
All subjects were followed for 1 year and were clinically and radiologically assessed at
baseline and at least once every two months, thereafter. In particular, subjects were evalu-
ated on 11 pre-specified neuroperformance measures, including an examination of cerebellar
function. In the study, the primary endpoint was survival and secondary endpoints included
neurological progression. In our analysis, we focused on the cerebellar examination measure
as our secondary endpoint. Of the 219 subjects with complete baseline information, 204
were observed to die, 100 subjects were observed to progress on the cerebellar examination
prior to death, and of the 15 subjects who did not die, 4 were observed to have cerebellar
progression.
Besides treatment assignment, other important baseline prognostic factors included
age, race, Karnofsky performance score, local vs. whole brain radiation, “active” vs. “quies-
cent” tumors, percent of tumor resection, previous use of nitrosoureas, and tumor histology
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(glioblastoma, anaplastic astrocytoma, oligodendroglioma, or other) at implantation, For the
219 subjects with complete prognostic inofrmation, Table 1 compares summary statistics for
each of these factors, stratified by treatment group. In Section 7, we will precisely define
2.3 Scientific Objective
The main objective is to evaluate the joint causal effect of treatment both on time to death
and on time to cerebellar progression, while adjusting for apriori-defined baseline prognostic
factors. The proper definition, much less estimation, of the effect of treatment on cerebellar
progression is subtle and will be discussed briefly in the following section after we introduce
the necessary notation. An extensive discussion is deferred to Section 5.
3 Data and Model
3.1 Data
Let Z = (V,W ′)′, where V denotes a binary treatment indicator and W is a q-dimensional
bounded, random vector of additional regressors with a mixture of possibly discrete and
continuous components. We assume that the kth component of Z has support of [lk, uk],
where −∞ < lk < uk <∞. Since the first component of Z is binary, l0 = 0 and u0 = 1. Let
Y 0 denote the logarithm of the time to death, X0 denote the logarithm of time of disease
progression, and C denote the logarithm of the censoring time due to random loss to follow-
up. X0 and Y 0 may be correlated. Let X = X0∧Y 0∧C, δ = I(X0 ≤ Y 0∧C), Y = Y 0∧C,
and ξ = I(Y 0 ≤ C). . The observed data for an individual are O = (X,Y, Z, δ, ξ). Note that
Y 0 censors X0 but not vice versa.
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3.2 Model
We specify our model without regard to censoring. We will address the issue of censoring in
the identifiability and estimation sections to follow.
We will assume, until Section 5, that X0 is well-defined for subjects with X0 6< Y 0.
When Y 0 denotes time to death, this assumption has been criticized by Kalbfleisch and
Prentice (1980), who argue that X0 should be considered as undefined. It is of interest to
consider estimation of causal effects under this latter assumption because
(i) in many studies, Y 0 does not denote time to death and the methodology developed
in this paper is applicable to such studies, e.g,, in a short-term study comparing the
effects of two antidepressant on time to first clinical improvement (X0) and to non-
compliance (Y 0), where scientific interest lies in regarding X0 as censored by Y 0 but
not vice-versa.
(ii) even when Y 0 is death time, settings may exist in which it is reasonable to regard X0
as well defined even when X0 ≮ Y 0. As in Robins and Greenland (2000), consider
a study in which a cohort of young children in a developing country are followed for,
say 5 years, for the development of abnormal blood pressure. Since children are highly
unlikely to die from hypertension, it might be reasonable to imagine the time that
they would have developed abnormal blood pressure had their death been prevented.
It would not be reasonable if, instead, we had followed a cohort of adults.
In Section 5.2.2, we provide conditions under which our method delivers consistent
estimates of the effect of treatment on X0, when X0 is considered undefined for subjects
X0 ≮ Y 0.
We now define the bivariate quantile-quantile regression model. The model is ex-
pressed as a quantile-quantile mapping between conditional distributions. Specifically, the
6
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model assumes that
SY 0(t|V = 1,W = w) = SY 0(r(t, w; η0a)|V = 0,W = w) (1)
SY 0(t|V = 0,W = w) = SY 0(r∗(t, w; η0b)|V = 0,W = 0) (2)
and
SX0(t|V = 1, Y 0 = r−1(u,w; η0a),W = w) = SX0(q(t, u, w; θ0a)|V = 0, Y 0 = u,W = w)
(3)
SX0(t|V = 0, Y 0 = r∗−1(u,w; η0b),W = w) = SX0(q∗(t, u, w; θ0b)|V = 0, Y 0 = u,W = 0)
(4)
where r(t, w; ηa), r
∗(t, w; ηb), q(t, u, w; θa), and q∗(t, u, w; θb) are known increasing func-
tions of t with well defined inverses with respect to their first arguments, r∗(t, 0; η0b) = t,
q∗(t, u, 0; θ0b) = t,
• r(t, w; η0a) is the quantile-quantile mapping function between the distribution of time
to death among treated subjects with covariates w and the distribution of time to
death among untreated subjects also with covariates w (see Figure 1),
• r∗(t, w; η0b) is the quantile-quantile mapping function between the distribution of time
to death among untreated subjects with covariates w and the distribution of time to
death among untreated subjects with covariates W = 0,
• q(t, u, w; θ0a) is the quantile-quantile mapping between the distribution of time to pro-
gression among treated subjects with covariates w who die at r−1(u,w; η0a) and the
distribution of time to progression among untreated subjects with covariates w who
die at u (see Figure 2), and
• q∗(t, u, w; θ0b) is the quantile-quantile mapping between the distribution of time to
progression among untreated subjects with covariates w who die at r∗−1(u,w; η0b) and
7
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the distribution of time to progression among untreated subjects with covariates w
who die at u with covariates W = 0.
Define η0 = (η
′
0a, η
′
0b)
′ and θ0 = (θ′0a, θ
′
0b)
′ as the true parameter vectors with η0a,
η0b, θ0a, and θ0b variation independent. Note that the right hand side of (3) is conditioned
on untreated subjects who die at time u with covariates w, whereas the right hand side
is conditioned on treated subjects with covariates w who die at the same percentile of the
conditional death time distribution as those who are untreated (since, from (1), SY 0(u|V =
0,W = w) = SY 0(r
−1(u,w; η0)|V = 1,W = w)).
The above model can be re-written as follows:
SY 0(t|V = 1,W = w) = SY 0(m(t, w; η0)|V = 0,W = 0) (5)
where m(t, w; η0) = r
∗(r(t, w; η0a), w; η0b) and
SX0(t|V = 1, Y 0 = m−1(u,w; η0),W = w) = SX0(l(t, u, w; η0b, θ0)|V = 0, Y 0 = u,W = w)
(6)
where l(t, u, w; η0b, θ0) = q
∗(q(t, r∗−1(u,w; η0b), w; θ0a), u, w; θ0b)
Define the following random variables
R˜(η0a) = V r(Y
0,W ; η0a) + (1− V )Y 0 (7)
M˜(η0) = V m(Y
0,W ; η0) + (1− V )r∗(Y 0,W ; η0b)
= M˜(Y 0, Z; η0) (8)
Q˜(η0a, θ0a) = V q(X
0, R˜(η0a),W ; θ0a) + (1− V )X0 (9)
L˜(η0, θ0) = V l(X
0, M˜(η0),W ; η0b, θ0) + (1− V )q∗(X0, M˜(η0),W ; θ0b)
= L˜(X0, M˜(Y 0, Z; η0), Z; θ0) (10)
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Under(1)-(6), we can prove the following lemma (see Appendix):
Lemma 1. (a) R˜(η0a) is independent of V given W ; (b) M˜(η0) is independent of Z; (c)
Q˜(η0a, θ0a) is independent of V given W and R˜(η0a); (d) L˜(η0, θ0) is independent of Z given
M˜(η0); (e) (M˜(η0), L˜(η0, θ0)) is independent of Z.
To link this model to other model forms, consider the following model:
Y 0 = V g1(W ; η0a) + g2(W ; η0b) + ν (11)
X0 = V h1(W, g2(W ; η0b) + ν; θ0a) + h2(W, ν; θ0b) + ² (12)
where g1, g2, h1 and h2 are specified functions of their arguments, g2(0; η0b) = 0, h2(0, ν; θ0b) =
0 and (ν, ²) are joint independent of Z. No restrictions are placed on the joint distribution
of ν and ². This model is a special case of the bivariate quantile-quantile regression model
with
r(t, w; η0a) = t− g1(w; η0a)
r∗(t, w; η0b) = t− g2(w; η0b)
m(t, w; η0) = t− g1(w; η0a)− g2(w; η0b)
q(t, u, w; θ0a) = t− h1(w, u; θ0a)
q∗(t, u, w; θ0b) = t− h2(w, u; θ0b)
l(t, u, w; θ0, η0b) = t− h1(w, g2(w; η0b) + u; θ0a)− h2(w, u; θ0b)
M˜(η0) = ν
L˜(η0, θ0) = ²
9
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The following special case of the above model with
g1(W ; η0a) = η0a
g2(W ; η0b) =W
′η0b
h1(W,u; θ0a) = θ0a
h2(W,u; θ0b) =W
′θ0b
is the bivariate linear regression model:
Y 0 = V η0a +W
′η0b + ν (13)
X0 = V θ0b +W
′θ0b + ² (14)
Lin, Wei, and Robins (1996) considered the special case without covariatesW . They referred
to their model as the bivariate location-shift model. Robins 1995 (a,b) and Peng and Fine
(2006) considered the case with covariates.
Henceforth, we again allow censoring by administrative censoring or loss to follow-up
C. Further, we assume that C and Z are jointly independent of M˜(η0) and L˜(η0, θ0).
4 Identifiability of η0 and θ0
4.1 Identifiability of η0
The parameter η0 in the bivariate quantile-quantile regression model is identifiable because
the conditional survivor function, SY 0(·|V = v,W = w), for v = 0, 1 and all w, is identifiable.
Under the independent censoring assumption and the fact that, given V and W , there is a
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one-to-one mapping between Y 0 and M˜(η0), and
λY 0(y|V = v,W = w) = λY 0(y|V = v,W = w,C ≥ y) (15)
where λY 0(y|·) = limdy→0 P [y ≤ Y 0 < y + dy|Y 0 ≥ y, ·]/dy is the hazard for Y 0 given ·.
The right hand side of (15) is the cause-specific hazard for death and is identifiable from the
distribution of the observed data. The conditional survivor function is identifiable since it
be written in terms of the cause-specific hazard as follows:
SY 0(t|V = v,W = w) = exp
(
−
∫ t
−∞
λY 0(y|V = v,W = w,C ≥ y)dy
)
,
Thus,
r(t, w; η0a) = S
−1
Y 0 (SY 0(t|V = 1,W = w)|V = 0,W = w)
r∗(t, w; η0b) = S−1Y 0 (SY 0(t|V = 0,W = w)|V = 0,W = 0)
m(t, w; η0) = S
−1
Y 0 (SY 0(t|V = 1,W = w)|V = 0,W = 0)
We assume that the conditional distribution Y 0 given V = v andW = w has positive support
on (−∞, τ ] and P [C > τ |V = v,W = w] > 0, for some specified −∞ < τ < ∞ and for all
v and w. So, r(t, w; η0a), r
∗(t, w; η0b), and m(t, w; η0) will be identifiable for t ∈ (−∞, τ ] for
all w. We only define these functions for t ∈ (−∞, τ ].
4.2 Identifiability of θ0
The identification argument for θ0 in bivariate quantile-quantile regression model is more
subtle. The conditional survivor function SX0(·|V = v, Y 0 = y,W = w) is only identifiable
on the support (−∞, y]. Under the independent censoring assumption and the fact that,
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given V and W and Y 0, there is a one-to-one mapping between X0 and L˜(η0, θ0),
λX0(x|V = v, Y 0 = y,W = w) = λX0(x|V = v, Y 0 = y,W = w,C ≥ y) (16)
where λX0(x|·) = limdx→0 P [x ≤ X0 < x + dx|X0 ≥ x, ·] is the hazard for X0 given ·. The
right hand side of (16) is identifiable from the observed data distribution for x ≤ y. Thus,
the conditional survivor function is identifiable on (−∞, y] since, we can write it as
SX0(t|V = v, Y 0 = y,W = w) = exp
(
−
∫ t
−∞
λX0(x|V = v, Y 0 = y,W = w,C ≥ y)dx
)
,
We assume that the conditional distributon of X0 given V = v, Y 0 = y, and W = w has
positive density on (−∞, y]. Since the right and left hand sides of (3,4,6) are conditioned on
different times of death, the quantile-quantile mapping functions q(t, u, w; θ0a), q
∗(t, u, w; θ0b),
and l(t, u, w; η0b, θ0) are only identified, respectively, on the sets
Aq = {(t, u, w) : t ≤ min{r−1(u,w; η0a), q(u, u, w; θ0a)}}
Aq∗ = {(t, u, w) : t ≤ min{r∗−1(u,w; η0a), q∗(u, u, w; θ0b)}}
Al = {(t, u, w) : t ≤ min{m−1(u,w; η0), l(u, u, w; η0b, θ0)}}
Since, by definition,
q(t, u, w : θ0a) = S
−1
X0(SX0(t|V = 1, Y 0 = r−1(u,w; η0a),W = w)|V = 0, Y 0 = u,W = w)
q∗(t, u, w : θ0b) = S−1X0(SX0(t|V = 0, Y 0 = r∗−1(u,w; η0b),W = w)|V = 0, Y 0 = u,W = 0)
l(t, u, w : η0a, θ0) = S
−1
X0(SX0(t|V = 1, Y 0 = m−1(u,w; η0),W = w)|V = 0, Y 0 = u,W = w)
we can see that these functions may not be identified off their respective sets above. For
example, if we had specified the model
q(t, u, w; θa) = (t− θa1) I ((t, u, w) ∈ Aq) + (t− θa2) I ((t, u, w) /∈ Aq)
12
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where θa = (θa1, θa2), θa1 and θa2 variation independent and θ0a = (θ0a1, θ0a2), then θ0a1 would
be identified but θ0a2 would not be. However, for most specifications for q(t, u, w; θ0a), the
function q(t, u, w; θ0a) even restricted to Aq uniquely determines θ0a and thus (by extrapola-
tion), the function the q(t, u, w; θ0a) on the complement of Aq as well. It follows that, under
such a specification, q(t, u, w; θ0a) is globally identified. We can make similar arguments for
the global identification of q∗(t, u, w; θ0b) and l(t, u, w; θ0). Identification of these functions
will imply that θ0 is identified.
5 Causal Interpretation of η0a and θ0a
To talk about causality, it is very useful to think in terms of potential outcomes (Rubin,
1974). Define Y 0(v) to be the logarithm of time to death if the subject, possibly contrary
to fact, had been given treatment v (v = 0, 1). Define X0(v) to be the logarithm of time to
disease progression under treatment v. We will discuss causal interpretations when X0(v) is
and is not well defined after Y 0(v).
Under randomization, V is independent of (W,Y 0(0), Y 0(1), X0(0) : X0(0) ≤ Y 0(0), X0(1) :
X0(1) ≤ Y 0(1)).
5.1 Interpretation of η0a
Under randomization, Model (1) can be written as
SY 0(1)(t|W = w) = SY 0(0)(r(t, w; η0a)|W = w) (17)
where SY 0(z)(·|W = w) is the continuously, differential conditional survivor function of Y 0(z)
given W = w. As a result, r(t, w; η0a) can be interpreted as the quantile-quantile mapping
function between the distribution of death under treatment and the distribution of death
13
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under no treatment, among subjects with covariates w (see Figure 1). Since the quantile-
quantile mapping function is a comparison of the distributions of potential outcomes on the
same cohort of subjects, namely those with covariates w, the function and its parameters
are causally interpretable. In contrast, the function r∗(t, w; η0b) and η0b are not causally
interpretable because W is not randomized.
It is useful to note that
r(t, w; η0a) = S
−1
Y 0(0)(SY 0(1)(t|W = w)|W = w)
and
r(Y 0(1), w; η0)
D(w)
= Y 0(0)
where
D(w)
= denotes equality in distribution given W = w.
Under the bivariate linear regression model (13,14), we have that r(t, w; η0) = t−η0a.
So, we see that η0a is the constant additive shift in the death time distribuion due to the causal
effect of treatment. Since W was not randomized η0b does not have a casual interpretation.
5.2 Interpretation of θ0a
We now consider conditions under which θ0a has a causal interpretation under randomization.
In Section 5.2.1, we assume X0 is well-defined for all subjects. In Section 5.2.2, we assume
X0 is defined only in subjects with X0 ≤ Y 0.
5.2.1 X0 is well-defined for all subjects.
Under randomization, model (1,3) can be written as
SX0(1)(t|Y 0 = r−1(u,w; η0a),W = w) = SX0(0)(q(t, u, w; θ0a)|Y 0 = u,W = w) (18)
14
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Further, suppose q(t, u, w; θ0a) = q(t, w; θ0a) is free of u for all (t, u, w). Then,
SX0(1)(t|W = w) = SX0(0)(q(t, w; θ0a)|W = w) (19)
So, when X0 is well defined for all subjects, q(t, w; θ0a) can be interpreted as the quantile-
quantile mapping function between the distribution of progression under treatment and the
distribution of progression under no treatment, among subjects with covariates w. That is,
q(t, w; θ0a) is the causal conditional quantile-quantile function S
−1
X0(0)(SX0(1)(t|W = w)|W =
w).
Now, suppose that q(t, w, u; θ0a) depends on u. Then, in general, q(t, w, u; θ0a) does
not have a causal interpretation. This reflects the fact that, except under special circum-
stances described in the next subsection, the subset of the population defined by the event
{Y 0 = r−1(u,w; η0a),W = w} will generally differ in the distribution of counterfactuals
{X0(0), X0(1)} than the subset of the population defined by the event Y 0 = u,W = w. It
follows that, even under the sharp null hypothesis
X0(1) = X0(0) with probability 1
of no treatment effect of X0, we would not expect q(t, u, w; θ0a) = t to hold for all (u,w).
Thus, q(t, u, w; θ0a) would not have a causal interpretation.
To understand the implications of this result, consider the bivariate regression model
specified in (11,12) where h1(w, u; θ0a) = h1(w; θ0a1) does not depend on u. Then, q(t, u, w; θ0a) =
t − h1(w; θ0a1). A goodness of fit test can be based on an expanded model in which
h1(w, u; θ0a) = h1(w;u; θ0a1) + θ0a2u in model (11,12). If the hypothesis θ0a2 = 0 is re-
jected, then q(t, u, w : θ0a) in the expanded model does not have a causal interpretation.
Even if the hypothesis is not rejected, and q(t, u, w; θ0a) = t− h1(w; θ0a1) on Aq, it is always
15
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possible that
q(t, w, u; θ0a) = (t− h1(w; θ0a1)I((t, u, w) ∈ Aq) + g(t, u, w; θ0a3)I((t, u, w) 6∈ Aq)
for some function g(t, u, w; θ0a3) defined on Acq. If g(t, u, w; θ0a3) 6= t − h2(w; θ0a1) for some
(t, u, w) ∈ Acq, then q(t, u, w; θ0a) 6= t− h1(w; θ0a,1) for all (t, u, w). Thus, q(t, u, w; θ0a) does
not have a causal interpretation. Furthermore, since q(t, u, w : θ0a) is only identified on Aq,
we cannot test from the data whether q(t, u, ; : θ0a) 6= t− h1(w; θ0a1) on Acq.
5.2.2 If X0 is not defined for subjects with X0  Y 0
In the previous subsection we saw that if X0 is well-defined for all subjects, then (i)
q(t, u, w; θ0a) is well defined for all (t, u, w) but only identified onAq and (ii) if q(t, u, w; θ0a) =
q(t, w; θ0a) for all (t, u, w) then q(t, w; θ0) had a causal interpretation as the causal quantile-
quantile function S−1X0(0)(SX0(1)|W=w(t|W = w).
If X0 is undefined for subjects with X0  Y 0, then (i) q(t, u, w; θ0a) is only defined
and identified on Aq and (ii) the distributions SX0(1)(t|W = w) and SX0(0)(t|W = w) are not
well-defined and thus, even if q(t, u, w; θ0a) = q(t, w; θ0a) where defined, q(t, w; θ0a) does not
have a causal interpretation, except under special circumstances. These circumstances are
that the following rank preservation assumption (Robins, 1995a) holds:
r(Y 0(1), w; η0) = Y
0(0) with probability 1(w)
This assumption implies that the rank ordering of subjects by Y 0 in the absence of treatment
is preserved under treatment.
Under rank preservation and randomization, we can now write model (1,3) as
SX0(1)(t|Y 0(0) = u,W = w) = SX0(0)(q(t, u, w; θ0a)|Y 0(0) = u,W = w) (20)
16
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for (t, u, w) ∈ Aq. Thus, q(t, u, w; θ0a) is, for (t, u, w) ∈ Aq, the quantile-quantile mapping
function between the distribution of disease progression under treatment and the distribution
of disease progression under no treatment, among subjects who die at time u under no
treatment and have covariates w (see Figure 2). Since the quantile-quantile mapping function
is a comparison of the distributions of the potential outcomes on X0(1) and X0(0) for a fixed
subset of subjects, namely those with die at time u under no treatment and covariates w,
the function and its parameters are causally interpretable. Thus, under rank preservation,
q(t, u, w; θ0a) has a causal interpretation even when it depends on u. Robins (1986, Section
12.2, 1995ab, 2000) introduced this idea of defining causal contrasts conditional on functions
of counterfactual survival times to deal with censoring by death. Frangakis and Rubin (2001)
later discussed the same idea under the rubric of “principal stratification.”
In many settings, the assumption of rank preservation is untenable. In that case,
when X0 is not defined for subjects with X0 6≤ Y 0, the causal effect of treatment on X0
will generally not be identfied in any subset of the study population. Sensitivity analysis
or bounding methods would be required,. As of now, the development of formal sensitivity
analysis methods that use all available failure time information remains an open problem.
6 Estimation
6.1 More Notation
Our objective is to use the observed data to draw inference about β0 = (θ0, η0). We assume
β0 lies in the interior of a compact set β. For notational covenience, let
NY 0(u; η) = I(M˜(Y, Z; η) ≤ u, ξ = 1)
17
Hosted by The Berkeley Electronic Press
and
NX0(u; θ, η) = I(L˜(X, M˜(Y, Z; η), Z; θ) ≤ u, δ = 1)
Let H(·, ·) denote the joint c.d.f. of Z and Y , FM˜,L˜(·, ·) denote the joint c.d.f. of M˜(η0) and
L˜(η0, θ0), and ΛM˜(·) and fM˜(·) denote the cumulative hazard and density functions of M˜(η0).
Let FZ denote the cumulative distribution function of Z, and SC and ΛC denote the survivor
and cumulative hazard functions of C, respectively. Let NC(t) = I(Y ≤ t, ξ = 0) and
MC(t) = NC(t) −
∫ t
−∞ I(Y ≥ u)dΛC(u)du. Throughout, true distributions are subscripted
by zero and expectations without subscripts are taken with respect to the true law of the
observed data, P0.
6.2 Estimating Function for η0
Consider the following estimating function for η0;
U1(O; β,H) =
∫ ∞
−∞
{a(Z)− EH [a(Z)|M˜(Y, Z; η) ≥ u]}dNY 0(u; η)
=
∫ ∞
−∞
{a(Z)− EH [a(Z)I(M˜(Y, Z; η) ≥ u)]
EH [I(M˜(Y, Z; η) ≥ u)]
}dNY 0(u; η)
=
∫ ∞
−∞
{a(Z)−
∫
z,y
a(z)I(M˜(y, z; η) ≥ u)dH(z, y)∫
z,y
I(M˜(y, z; η) ≥ u)dH(z, y) }dNY 0(u; η)
where a(Z) is a bounded function of Z with the same dimension as η.
Let V1(β, P ) =
∫
U1(o; β,H)dP (o), where H is a function of P , the probability mea-
sure assigned to O. In the Appendix, we prove the following lemma;
Lemma 2. V1(β0, P0) = E[U1(O; β0, H0)] = 0.
The above estimating function is a generalization of one proposed by Tsiatis (1990)
for classic linear regression with censored outcomes. For this special case, the estimating
18
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function, with a(Z) = Z, reduces to:
U1(O; β,H) =
∫ ∞
∞
{
Z − EH [ZI(Y − Z
′η ≥ u)]
EH [I(Y −W ′η ≥ u)]
}
dNY 0(u)
Working the residual death time scale, this estimating function compares, for a subject who
has been observed to die, his observed covariate vector to the expected value of the covariate
vectors of subjects still at risk for death at that time. When covariates W are excluded,
the resulting estimating function is the same one proposed by Louis (1981), Wei and Gail
(1983), and subsequently utilized by Lin, Robins, and Wei (1996) and Peng and Fine (2006).
6.3 Estimating Function of θ0
Assume η0 is known. Now, consider the following estimating function:
U2(O; θ, η0,H)
=
∫ ∞
−∞
∫ ∞
−∞
{
b(Z, s, u)− EP [b(Z, s, u))|L˜(Y, M˜(Y,Z; η0), Z; θ) ≥ u, M˜(Y,Z; η0) = s, ξ = 1]
}
dNX0(u; θ, η0)dNY 0(s; η0)
=
∫ ∞
−∞
∫ ∞
−∞
{
b(Z, s, u)− EP [b(Z, s, u)I(L˜(Y, s, Z; θ) ≥ u)|M˜(Y, Z; η0) = s, ξ = 1]
EP [I(L˜(Y, s, Z; θ) ≥ u)|M˜(Y,Z; η0) = s, ξ = 1]
}
dNX0(u; θ, η0)dNY 0(s; η0)
=
∫ ∞
−∞
∫ ∞
−∞
{
b(Z, s, u)− EP [b(Z, s, u)I(L˜(M˜
−1(s, Z; η0), s, Z; θ) ≥ u)|M˜(Y, Z; η0) = s, ξ = 1]
EP [I(L˜(M˜−1(s, Z; η0), s, Z; θ) ≥ u)|M˜(Y,Z; η0) = s, ξ = 1]
}
dNX0(u; θ, η0)dNY 0(s; η0)
=
∫ ∞
−∞
∫ ∞
−∞
{
b(Z, s, u)− EH [b(Z, s, u)I(L˜(M˜
−1(s, Z; η0), s, Z; θ) ≥ u)|M˜(Y,Z; η0) ≥ s]
EH [I(L˜(M˜−1(s, Z; η0), s, Z; θ) ≥ u)|M˜(Y, Z; η0) ≥ s]
}
dNX0(u; θ, η0)dNY 0(s; η0)
=
∫ ∞
−∞
∫ ∞
−∞
{
b(Z, s, u)− EH [b(Z, s, u)I(L˜(M˜
−1(s, Z; η0), s, Z; θ) ≥ u, M˜(Y, Z; η0) ≥ s)]
EH [I(L˜(M˜−1(s, Z; η0), s, Z; θ) ≥ u, M˜(Y, Z; η0) ≥ s)]
}
dNX0(u; θ, η0)dNY 0(s; η0)
=
∫ ∞
−∞
∫ ∞
−∞
{
b(Z, s, u)−
∫
z,y
b(z, s, u)I(L˜(M˜−1(s, z; η0), s, z; θ) ≥ u, M˜(y, z; η0) ≥ s)dH(z, y)∫
z,y
I(L˜(M˜−1(s, z; η0), s, z; θ) ≥ u, M˜(y, z; η0) ≥ s)dH(z, y)
}
dNX0(u; θ, η0)dNY 0(s; η0)
where b(Z, s, u) is a specified function of Z, s and u with the same dimension as θ.
Let V2(β, P ) =
∫
U2(o, β,H)dP (o). In the Appendix, we prove the following lemma:
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Lemma 3. V2(β0, P0) = E[U2(O; β0, H0)] = 0.
In the context of the bivariate linear regression model, the above estimating function,
with b(Z, s, u) = Z, reduces to
U2(O; θ, η,H) =
∫ ∞
−∞
∫
−∞
{
Z − EH [ZI(Z
′(η − θ) ≥ u− s, Y − Z ′η ≥ s)]
EH [I(Z ′(η − θ) ≥ u− s, Y − Z ′η ≥ s)]
}
dNX0(u; θ)dNY 0(s; η)
In this estimating function, one compares, for a subject who is observed to die and progress,
his observed covariate vector to the expected value of the the covariate vectors for subjects
who are observed to die and share the same observed death time (on the residual death time
scale) and who at are risk for death at the progression time (on the residual progression
scale).
Without covariates W , this latter estimating function is different than that proposed
by Lin, Robins, and Wei (1996). The extension of their estimating function to covariates W
would be ∫ ∞
−∞
{Z − EP [Z|X˜(β) ≥ u]}dN˜X0(u; β)
where X˜(β) = min(X0 − Z ′θ, Y − Z ′η − d(β)), δ˜(β) = I(X0 − Z ′θ ≤ Y − Z ′η − d(β)),
N˜X0(u; β) = I(X˜(β) ≤ u, δ˜(β) = 1), d(β) =
∑q
k=1(θk − ηk){I(θk − ηk > 0)uk + I(θk − ηk <
0)lk}. The function d(β) is chosen so that (1) it does not depend on Z and (2) δ˜(β0) = 1
implies that δ = 1. As a result, progression events are artificially censored. The above
estimating function can be shown to have mean zero at the truth. The problem with their
estimating function is that it is not practically useful for the setting in which high-dimensional
covariates W are included. In this setting, there will be excessive artificial censoring.
Arguing that excessive artificial censoring with high-dimensional covariates is caused
by the fact that d(β) is invariant across subjects, Peng and Fine (2006) introduced a U-
statistic based estimating function that performs artificial censoring within pairs of subjects
and then sums over all possible pairs. Their approach allows the trimming to be differ across
20
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pairs of subjects, thus reducing the level of artificial censoring. Specifically, for pair (i, j),
the contribution to the estimating function is
(Zi − Zj)
{
δ˜ij(β)I(X˜j(β) ≥ X˜i(β) + δ˜ji(β)I(X˜i(β) ≥ X˜j(β)
}
where X˜ij(β) = min(X
0
i − Z ′iθ, Yi − Z ′iη − dij(β)), δ˜ij(β) = I(X0i − Z ′iθ ≤ Yi − Z ′iη − dij(β))
and dij(β) = max{0, (θ−η)′Zi, (θ−η)′Zj}. The continuing need for artificial censoring could
possibly adversely affect the efficiency of their estimator compared to ours. See below for
further discussion of this issue.
6.4 Estimation of β0
Let V (β, P ) = (V1(β, P ), V2(β, P ))
′. Since V (β, P0) is continuous and differentiable in β and
V (β0, P0) = 0, it is natural to think of estimating β0 as the solution to V (β, Pn) = 0, where Pn
is the empirical distribution of the observed data. Unfortunately, V (β, Pn) is discontinuous
in β. Thus, we propose to estimate β0 as the maximizer, βn, of Qn(β) = −V (β, Pn)′V (β, Pn).
In the next section, we show that βn is a consistent and asymptotically normal estimator of
β0 and we construct a consistent estimator of its asymptotic variance.
7 Large Sample Theory
Our results rely on high-level framework for large sample estimation developed by Newey
and McFadden (NM;1994). For convenience, in Section 5.1, we reproduce their Theorems
7.1, 7.2 (withW = I), and 7.4. In Section 5.2, we introduce regularity conditions. In section
5.3, we present two lemmas that pave our way for the main large sample results, which are
stated as two Theorems in Section 5.4. In what follows, let Q0(β) = −V (β, P0)′V (β, P0).
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7.1 Theorems of Newey and McFadden
Theorem 1 (7.1 of NM). If there is a function Q0(β) such that (i) Q0(β) is uniquely
maximized at β0; (ii) β is compact; (iii) Q0(β) is continuous; (iv) Qn(β) converges uniformly
to Q0(β), then βn converges in probability to β0
Theorem 2 (7.2 of NM). Suppose (i) βn converges in probability to β0; (ii) V (β0, P0) = 0;
(iii) V (β, P0) is differentiable at β0 with derivative G(β0, P0); (iv) β0 is in the interior of
β; (v)
√
nV (β0, Pn)
D→ N(0,Σ(β0, P0)); ( vi) for any ²n → 0, sup‖β−β0‖≤²n
√
n‖V (β, Pn) −
V (β0, Pn)− V (β, P0)‖/{1 +
√
n‖β − β0‖} P→ 0. Then,
√
n(βn − β0) D→ N(0, G(β0, P0)−1Σ(β0, P0)G(β0, P0)−1′).
LetG†(βn, Pn)) be a numerical derivative estimator ofG(β0, P0), where the jth column
of G†(β, Pn)) is
G†j(β, Pn) = {V (β + ej²n, Pn)− V (β − ej²n, Pn)}/(2²n) (21)
and ej is the jth unit vector.
Theorem 3 (7.4 of NM). Suppose ²n → 0 and ²n
√
n→∞. If the conditions of Theorems
1 and 2 hold, then G†(βn, Pn)
P→ G(β0, P0).
7.2 Regularity Conditions
Let
f1(z, y, u; β) ≡ I(M˜(y, z; η) ≥ u)
f2(z, y, u, s; β) ≡ I(L˜(M˜−1(s, z; η), s, z; θ) ≥ u, M˜(y, z; η) ≥ s).
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Partition Z into its continuous components Zc and its discrete components Zd.
RC1: Let the parameter space of β be a Euclidean sphere, that is, β = {β :‖ β ‖≤ M} for
some M <∞.
RC2: β0 lies in the interior of β
RC3: V (β, P0) = 0 has only one solution in β.
RC4: For some L, ‖Z‖ < L with probability 1.
RC5: Assume that
G1 ≡ {O → U1(O, β,H) : β,H} is a uniformly bounded P0-Donsker class,
F1 ≡ {(z, y)→ f1(z, y, u; β) : u, β} is a uniformly bounded H0-Donsker class,
and with probability 1,
I(ξ = 1)
∫
f1(z, y, M˜(Y, Z; η); β)dH0(y, z) > δ > 0
for some δ > 0 uniformly in β ∈ β.
RC6: Assume that
G2 ≡ {O → U2(O; β,H) : β,H} is a uniformly bounded P0-Donsker class,
F2 ≡ {(z, y)→ f2(z, y, u, s; β) : u, s, β} is a uniformly bounded H0-Donsker class,
Fb ≡ {z → b(z, s) : s} is a uniformly bounded H0-Donsker class,
and with probability 1,
I(δ = ξ = 1)
∫
f2(z, y, L˜(X, M˜(Y, Z; η), Z; θ), M˜(Y, Z; η); β)dH0(y, z) > δ
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for some δ > 0, uniformly in β ∈ β.
RC7: Within all the possible levels of (δ, ξ, Zd), the sub-distribution of (X, Y, Zc) is absolutely
continuous w.r.t. Lebesgue measure.
RC8: The derivative (with respect to β) of V (β, P0), G(β, P0), exists, is invertible and con-
tinuous at β0
The regularity conditions RC1-RC4 are standard, and state, beyond boundedness
conditions on the parameter space for β and Z, that the estimating equation asymptotically
uniquely identifies the true parameter value. RC7 and RC8 are also standard smoothness
condition necessary to make our estimator a smooth enough function of the empirical dis-
tribution so that it is asymptotically linear, and thus asymptotically normally distributed
(that is, it behaves as a sample mean in first order).
The Donsker class conditions RC5 and RC6 are necessary in order to establish the
wished asymptotic linearity. For a given class (e.g., G1), it holds, if each of the functions in
this class, considered as a multivariate real valued function in (x, y, zc), given (δ, ξ, Zd), have
a uniform sectional variation norm bounded by a universal constant (Gill, van der Laan,
Wellner, 1994). The uniform sectional variation norm of a multivariate function is defined
as the supremum over all its sections of the regular variation norm of the given section
of the function, where a section of a multivariate function is one of the lower dimensional
functions one obtains by fixing one or more of the coordinates. To establish such a result
one typically assumes that, within levels of (δ, ξ, Zd), the support of (X, Y, Zc) is compact.
In words, these classes are Donsker classes if, within levels of (δ, ξ, Zd), they are reasonably
smooth (regarding changes in value, e.g. number of jumps) functions in (X, Y, Zc), and that
(X, Y, Zc) has compact support. We refer to van der Vaart, Wellner (1996) for many more
examples of Donsker classes.
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7.3 Two Lemmas
The following lemmas provide us with a linear expansion of V (β, Pn)− V (β, P0) uniform in
β, which will be fundamental in proving consistency and asymptotic normality of βn. The
proof of Lemma 4 is provided in the Appendix. Lemma 3 follows the same logic. We will
use the notation Pf =
∫
f(x)dP (x).
Lemma 4. Under regularity conditions RC4 and RC5,
V1(β, Pn)− V1(β, P0) = (Pn − P0)IC1(· | β, P0) +Rn,1(β, P0),
where
IC1(O | β, P0) = U1(O; β,H0)−
∫
a(Z)f1(Z, Y, u; β)∫
f(z, y, u; β)dH0(y, z)
E[dNY 0(u, η0)]+∫
f1(Z, Y, u; β)
∫
a(z)f1(z, y, u; β)dH0(y, z)(∫
f1(z, y, u; β)dH0(y, z)
)2 E[dNY 0(u, η0)],
{O → IC1(O | β, P0) : β ∈ β} is a P0-Donsker class, and supβ∈β ‖ Rn,1(β, P0) ‖=
oP0(1/
√
n).
Lemma 5. Under regularity conditions RC4 and RC6,
V2(β, Pn)− V2(β, P0) = (Pn − P0)IC2(· | β, P0) +Rn,2(β, P0),
where
IC2(O | β, P0) = U2(O; β,H0)−
∫
b(Z, s, u)f2(Z, Y, u, s; β)∫
f2(z, y, u, s; β)dH0(y, z)
E[(dNX0(u, θ)dNY 0(s, η0))]+∫
f2(Z, Y, u, s; β)
∫
b(z, s)f2(z, y, u, s; β)dH0(y, z)(∫
f2(z, y, u, s; β)dH0(y, z)
)2 E[(dNX0(u, θ)dNY 0(s, η0))],
{O → IC2(O | β, P0) : β ∈ β} is a P0-Donsker class, and supβ∈β ‖ Rn,2(β) ‖= oP0(1/
√
n).
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Thus, we have that
V (β, Pn)− V (β, P0) = (Pn − P0)IC(· | β, P0) +Rn(β, P0),
where IC(· | β, P0) = (IC1(· | β, P0), IC(· | β, P0))′ andRn(β, P0) = (Rn,1(β, P0), Rn,2(β, P0))′.
7.4 Large Sample Results
7.4.1 Consistency
Under conditions RC1 and RC3, we know that conditions (i) and (ii) of Theorem 1 are
satisfied. Furthermore, under condition RC7, we have that V (β, P0) is continuous in β, and
thus condition (iii) of the general consistency Theorem 1 holds. Finally, under RC4-RC6 (i.e,
the conditions of Lemmas 3 and 4, we have sup
β∈β ‖ V (β, Pn) − V (β, P0) ‖= OP0(1/
√
n).
This tells us that condition (iv) of Theorem 1 holds. Thus, we are in the position to state
the following theorem:
Lemma 6. Under conditions RC1,RC3-RC7, Theorem 1 applies and βn is asymptotically
consistent.
7.4.2 Asymptotic Normality
We now work on the verification of the conditions of the general asymptotic normality
Theorem 2. Lemma 5 verifies condition (i) of Theorem 2. Lemmas 1 and 2 verify condition
(ii). Conditions (iii) and (iv) hold by assumptions RC2 and RC8. From Lemmas 3 and 4,
we know that
√
n{V (β0, Pn)− V (β0, P0)} = 1√
n
n∑
i=1
IC(Oi | β0, P0) + oP0(1),
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where IC(O | β, P0) = (IC1(O | β, P0), IC2(O | β, P0))>. This proves condition (v) of
Theorem 2 with Σ(β0, P0) = E[IC(O | β0, P0)IC(O | β0, P0)>].
Regarding condition (vi) of Theorem 2, we note that
δ(n) ≡ V (β0 + ²n, Pn)− V (β0, Pn)− V (β0 + ²n, P0)
= V (β0 + ²n, Pn)− V (β0 + ²n, P0)− {V (β0, Pn)− V (β0, P0)} .
This shows that the term δ(n) in condition (vi) can be expected to be second order for
any sequence ²n converging to zero, and thus that condition (vi) of Theorem 2 is a natural
condition. By application of the linear expansions of Lemmas 3 and 4 at β0 + ²n and β0,
respectively, we have that
V (β0 + ²n, Pn)− V (β0 + ²n, P0) = (Pn − P0)IC(· | β0 + ²n, P0) + oP0(1/
√
n)
V (β0, Pn)− V (β0, P0) = (Pn − P0)IC(· | β0, P0) + oP0(1/
√
n).
Thus,
δ(n) = (Pn − P0){IC(· | β0 + ²n, P0)− IC(· | β0, P0)}+ oP0(1/
√
n).
Lemmas (3) and (4) also teach us that {O → IC(O | β, P0) : β} is a P0-Donsker class. It is
well known from empirical process theory that, if 1) fn falls in a Donsker class with proba-
bility tending to 1, and 2)
∫
f 2n(o)dP0(o) converges to zero in probability, then
∫
fn(o)d(Pn−
P0)(o) = oP0(1/
√
n) (van der Vaart, Wellner, 1996). Consequently, δ(n) = oP0(1/
√
n) if∫ {IC(O | β0 + ²n, P0)− IC(O | β0, P0)}2dP0(O)→ 0 in probability. It is easy to verify that
the latter holds under the regularity conditions (in particular, RC8). Now, we can state the
following lemma:
Lemma 7. Under conditions RC1-RC8, Theorem 2 applies and βn is asymptotically linear
with influence curve
−G(β0, P0)−1IC(O | β0, P0).
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In particular,
√
n(βn − β0) D⇒ N(O,G(β0, P0)−1ΣG(β0, P0)−1′), where Σ(β0, P0) = E[IC(O |
β0, P0)IC(O | β0, P0)′].
7.4.3 Variance Estimation
Under RC1-RC8, Theorem 3 tells us that we can estimate G(β0, P0) by G
†(βn, Pn) given
in Equation (3). We can also estimate Σ(β0, P0) by Σ(βn, Pn). Thus, we can consistently
estimate the asymptotic variance of βn by G
†(βn, Pn)−1Σ(βn, Pn)G†(βn, Pn)−1>. The consis-
tency of this estimate of the asymptotic variance follows under the same conditions as we
needed for the asymptotic linearity of βn.
8 Simulation Studies
We conducted two simulation studies to evaluate the performace of our estimator. For each
study, we simulated three covariates (Z = (Z(1), Z(2), Z(3))′) in a sequential fashion: Z(1) was
generated as a Bernoulli random variable with probability 0.5, Z(2) given Z(1) was generated
as a truncated (at 2 and 7.5) normal random variable with mean 4.5+0.5Z1 and variance 1,
and Z(3) given Z(1) and Z(2) was generated as a Bernoulli random variable with probability
0.3 + 0.2 ∗ Z1. The true value of θ0 and η0 in (1) and (2) was set equal to (0.4,−0.1,−0.2)
and (0.2,−0.3,−0.4), respectively. We assumed that the censoring time was independent
and followed the log of a uniform (0,c) random variable. 1000 simulated datasets of 250
independent subjects were created for each study.
In the first simulation study, exp(²) and exp(ν) were generated from a bivariate
exponential with hazard rates 1.0 and 0.2, respectively, and correlation coefficient 0.25. We
set c =??. On average, the censoring rate for death and disease progression was 23.2% and
44.36%, respectively; both progression and death were observed on 40.4% of subjects. 1.8%
of the simulations failed to converge. The results of the converged simulations are presented
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to Table 2 (a). As we see, our estimator of the regression parameters has low bias. This is
seen by comparing the Monte Carlo average (M.C. Avg.) over simulations to the truth. In
addition, our influence-based standard error estimator works well; the Monte Carlo average
of the estimated standard errors (Avg. Est. S.E.) is close to the Monte Carlo standard
deviation (M.C. S.D.) of the simulated estimates. Finally, the coverage rate (Cov. Prob.) of
95% Wald-based confidence is close to the nominal level.
In the second simulation study, ² and ν were generated from a bivariate normal
with means 0.0 and 1.5, respectively, variances 1 and correlation 0.25. Here, we set c = 8.
On average, the censoring rate for death and disease progression was 21.6% and 44.1%,
respectively; both progression and death were observed on 44.8% of subjects. 1.1% of the
simulations failed to converge. As seen in Table 2 (b), our estimation procedure performs
well.
9 Analysis of Glioma Trial
In our analysis of the glioma trial, V is the indicator of assignment to the carmustine ploymer
arm and W is a 10× 1 vector of prognostic factors including resection greater than 75%, age
in years (continuous), white, Karnofsky score greater than 70, local radiation, previous use
of nitrosoureas, active tumor histology, anaplastic astrocytoma subtype, oliodendroglioma
subtype, and other subtype. To evaluate whether a causal interpretation can be (statis-
tically) ruled out, we first fit model (11,12) with g1(W ; η0a) = η0a, g2(W ; η0b) = W
′η0b,
h1(W,u; θ0a) = θ0a1 + θ0a2u and h2(W,u; θ0b = W
′θ0b and tested whether the null hypothesis
θ0a2 = 0 can be rejected at the 0.05 level. In our estimating function, we let a(Z) = Z and
b(Z, s, u) = (Z ′, V u)′. The resulting estimate of θ0a2 is -0.0079, with standard error 0.21.
Using a Wald test, we are unable to reject the null.
Next, we fit the reduced model (13,14). For this model, we used our estimating
29
Hosted by The Berkeley Electronic Press
function approach (SRL) and that of Peng and Fine (2006;PF). The results of are shown
in Table 2. Both approaches produce the same inference for regression coefficients of the
death model (see final column). Carmustine ploymer appears to increase the time to death
relative to placebo polymer (95% CI: 0.06,0.50). These results are consistent with Brem et
al. (1995), who fit a proportional hazards regression version of our model for death and
found an adjusted hazard ratio of 0.67 (95% CI: 0.51 -0.90).
For cerebellar progression, inference about the effect of carmustine ploymer depends
on the estimation technique. Our estimating function approach, using a(Z) = Z and
b(Z, s, u) = Z, shows, under rank preservation, that carmustine polymer also increases the
time to progression (95%: 0.07,0.68). In contrast, the approach of Peng and Fine (2006),
who use a resampling-based standard error estimator, do not suggest a benefit of treatment
with carmustine on cerebellar progression (95% -0.23,0.92) 1. In fact , 9 of 11 standard error
estimates are smaller using our approach than that of Peng and Fine (2006). Our progression
results are consistent with Westphal et al. (2003), who reported the results of a follow-up
clinical trial.
10 Discussion
In this paper we have imbedded the bivariate linear regression model for the analysis semi-
competing risks data into a more general quantile-quantile regression model. The use of this
more general model allowed us to clarify the conditions under which the model parameters
have a causal interprestation. Specifically, in settings in which X0 is well-defined even
when X0 ≮ Y 0, we showed in Section 5.2.1 that, even in a randomized experiment, if the
quantile-quantile function q (t, u, w; θ0a) depends on u, the parameter θ0a does not have a
causal interpretation and, in fact, no progression-related causal contrast is identified from
semi-competing risks data. Now the bivariate linear regression model is a special case of
1We are grateful to Limin Peng for conducting this analysis
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our quantile-quantile model for which q (t, u, w; θ0a) is free of u and thus θ0a has a causal
interpretation. However, the dependence of q (t, u, w; θ0a) on u is testable from the data.
Thus we recommend that one never use a bivariate linear regression model without first
testing whether q (t, u, w; θ0a) is free of u. If the test rejects, one should also reject the
bivariate linear regression model and any causal interpretation for θ0a.
In settings in which X0 is not defined when X0 ≮ Y 0, we showed that, in a random-
ized study, the quantile-quantile function q (t, u, w; θ0a) has a causal interpretation, even if
it depends on u, under a strong rank preservation assumption. As this rank preservation
assumption is often unlikely to hold, it would be useful to develop a sensitivity analysis
methodology for our model depending on a non-identified sensitivity-parameter that could
be used estimate the quantile -quantile function linking the distribution of the progression
counterfactual X0 (1) with the counterfactual X0 (0) given Y 0 (0) = u,W = w on the set
where X0 (1) and X0 (0) are well-defined.
Finally in this paper we have not attempted to construct a semiparametric efficient
estimator of θ0a, although we plan to do so in subsequent work. Even so, in our empirical
example, our estimator of θ0a had an estimated variance much smaller than did the rank
estimator of Peng and Fine (2006). The reader may find this suprising because Peng and
Fine (2006) reported results of a simulation study that, in a setting of 2-dimensional Z,
demonstated that their rank estimator had better finite-sample effiiciency properties than
even the semiparametric efficient estimator of Tsiatis in the smaller model that assumes
that X0 and Y 0 are independent given Z . However, the semiparametric efficient estimator
depends on a smoothed estimate of the derivative of the log hazard of X0 − θT0 Z. Peng and
Fine’s (2006) method of selecting their smoothing parameter resulted in a small bandwidth
and thus large second order variance terms in the expansion of the semiparametric efficient
estimator, resulting in a loss of efficiency in finite samples. The performance of the semi-
parametric efficient estimator could have been improved, possibly considerably, by either
using a larger bandwidth or by using a low dimensional parametric model for the hazard
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of X0 − θT0 Z that included the truth. This latter estimator would be referred to as locally,
but not globally, semiparamtric efficient. Since we did not attempt to construct a semi-
parametric efficient estimator, our estimator did not require us to estimate any non- root-n
estimable function (such as the derivative of a log hazard) and thus does not include second
order variance terms in its expansion. As a consequence, it would not be suprising for our
estimator to be more efficient than Peng and Fine’s (2006), although we have not carried
out either a detailed comparison, either analytically or by simulation.
Appendix
Proof of Lemma 1:
Part (a) follows since
P [R˜(η0a) > t|V = 1,W = w] (7)= P [r(Y 0,W ; η0a) > t|V = 1,W = w]
= P [Y 0 > r−1(t, w; η0a)|V = 1,W = w]
(1)
= SY 0(t|V = 0,W = w)
P [R˜(η0a) > t|V = 0,W = w] (7)= SY 0(t|V = 0,W = w)
Part (b) follows since
P [M˜(η0) > t|V = 1,W = w] (8)= P [Y 0 > m−1(t, w; η0)|V = 1,W = w] (5)= SY 0(t|V = 0,W = 0)
P [M˜(η0) > t|V = 0,W = w] (8)= P [Y 0 > r∗−1(t, w; η0b)|V = 0,W = w] (2)= SY 0(t|V = 0,W = 0)
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Part (c) follows since
P [Q˜(η0a, θ0a) > t|V = 1, R˜(η0a) = u,W = w]
(7,9)
= P [q(X0, R˜(η0a), w; θ0a) > t|V = 1, r(Y 0, w; η0a) = u,W = w]
= P [X0 > q−1(t, R˜(η0a), w; θ0a)|V = 1, Y 0 = r−1(u,w; η0a),W = w]
(3)
= SX0(t|V = 0, Y 0 = u,W = w)
P [Q˜(η0a, θ0a) > t|V = 0, R˜(η0a) = u,W = w] (7,9)= SX0(t|V = 0, Y 0 = u,W = w)
Part (d) follows since
P [L˜(η0, θ0) > t|V = 1, M˜(η0) = u,W = w]
(8)
= P [L˜(η0, θ0) > t|V = 1, Y 0 = m−1(u,w; η0),W = w]
(10)
= P [X0 > l−1(t, u, w; η0b, θ0)|V = 1, Y 0 = m−1(u,w; η0),W = w]
(6)
= SX0(t|V = 0, Y 0 = u,W = 0)
P [L˜(η0, θ0) > t|V = 0, M˜(η0) = u,W = w]
(8,10)
= P [q∗(X0, u, w; θ0b) > t|V = 0, Y 0 = r∗−1(u,w; η0b),W = w]
= P [X0 > q∗−1(t, u, w; θ0b)|V = 0, Y 0 = r∗−1(u,w; η0b),W = w]
(4)
= SX0(t|V = 0, Y 0 = u,W = 0)
Part (e) follows from results (b) and (d).
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Proof of Lemma 2:
V1(η0, P0) = E[
∫ ∞
−∞
{a(Z)− E[a(Z)I(M˜(Y, Z; η0) ≥ u)]
E[I(M˜(Y, Z; η0) ≥ u)]
}dNY 0(u; η0)]
=
∫ ∞
−∞
{E[a(Z)dNY 0(u; η0)]− E[a(Z)I(M˜(Y, Z; η0) ≥ u)]
E[I(M˜(Y, Z; η0) ≥ u)]
E[dNY 0(u; η0)]}
=
∫ ∞
−∞
{E[a(Z)I(M˜(Y, Z; η0) ≥ u)]dΛM˜(u)−
E[a(Z)I(M˜(Y, Z; η0) ≥ u)]
E[I(M˜(Y, Z; η0) ≥ u)]
E[I(M˜(Y, Z; η0) ≥ u]dΛM˜(u)}
= 0
Proof of Lemma 3:
V2(θ0, η0, P0)
= E
[∫ ∞
−∞
∫ ∞
−∞
{b(Z, s, u)− E[b(Z, s, u)|L˜(Y, M˜(Y, Z; η0), Z; η0) ≥ u, M˜(Y, Z; η0) = s, ξ = 1]}
dNX0(u; θ0)dNY 0(s; η0)]
=
∫ ∞
−∞
∫ ∞
−∞
E[b(Z, s, u)dNX0(u; θ0)dNY 0(s; η0)]− (22)∫ ∞
−∞
∫ ∞
−∞
E[b(Z, s, u)I(L˜(Y, M˜(Y, Z; η0), Z; η0) ≥ u, M˜(Y, Z; η0) = s, ξ = 1)]
E[I(L˜(Y, M˜(Y, Z; η0), Z; η0) ≥ u, M˜(Y, Z; η0) = s, ξ = 1)]
E[dNX0(u; θ0)dNY 0(s; η0)]
(23)
Now, note that, for any function k(Z, s),
E[k(Z, s)dNX0(u; θ0)dNY 0(s; η0)]
= E[I(M˜(Y0, Z; η0) ∈ ds)I(L˜(X0, M˜(Y 0, Z; η0), Z; θ0) ∈ ds)k(Z, s)I(M˜−1(s, Z; η0) ≥ L˜−1(u, s, Z; θ0), C ≥ M˜−1(s, Z; η0))]
= FM˜,L˜(du, ds)E[k(Z, s)I(M˜
−1(s, Z; η0) ≥ L˜−1(u, s, Z; θ0), C ≥ M˜−1(s, Z; η0))]
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and
E[k(Z, s)I(L˜(Y, M˜(Y, Z; η0), Z; η0) ≥ u, M˜(Y,Z; η0) = s, ξ = 1)] (24)
= E[k(Z, s)I(M˜(Y 0, Z; η0) ∈ ds)I(M˜−1(s, Z; η0) ≥ L˜−1(u, s, Z; θ0), C ≥ M˜−1(s, Z; η0))]
= FM˜ (ds)E[k(Z, s)I(M˜
−1(s, Z; η0) ≥ L˜−1(u, s, Z; θ0), C ≥ M˜−1(s, Z; η0))]
where the last equalities in (6) and (7) follow by the joint independence of (M˜(η0), L˜(η0, θ0))
and (C,Z). Using (6) and (7) with k(Z, s) set equal to b(Z, s, u) and 1, respectively, we can
then plug the relevant expectations into (4) and (5). We then obtain that
V2(θ0, η0, P0) =
∫ ∞
−∞
∫ ∞
−∞
E[b(Z, s, u)I(M˜−1(s, Z; η0) ≥ L˜−1(u, s, Z; θ0), C ≥ M˜−1(s, Z; η0))]F²,ν(du, ds)−∫ ∞
−∞
∫ ∞
−∞
E[b(Z, s, u)I(M˜−1(s, Z; η0) ≥ L˜−1(u, s, Z; θ0), C ≥ M˜−1(s, Z; η0))]
E[I(M˜−1(s, Z; η0) ≥ L˜−1(u, s, Z; θ0), C ≥ M˜−1(s, Z; η0))]
×
E[I(M˜−1(s, Z; η0) ≥ L˜−1(u, s, Z; θ0), C ≥ M˜−1(s, Z; η0))]F²,ν(du, ds)
Note the cancellation of the cancelation of like terms in the numerator and the denominator
in the second term of the substraction. The remaining terms in the subtraction are now
identical, yielding that V2(θ0, η0, P0) = 0.
Proof of Lemma 5:
Note that we can write EPn [U2(O; β,Hn)]− E[U2(O; β,H0)] is equal to
EPn−P0 [U2(O; β,Hn)−U2(O; β,H0)]+EPn−P0 [U2(O; β,H0)]+E[U2(O; β,Hn)−U2(O; β,H0)].
(25)
Under the condition that G2 is a P0-Donsker class (RC5), we know by empirical process
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theory (van der Vaart and Wellner, 1996), that if
∫
{U2(O; β,Hn)− U2(O; β,H0)}2 dP0(O) P0→ 0 (26)
then the first and second terms in (25) are oP0(1/
√
n) and OP0(1/
√
n), respectively. Result
(9) follows straightforwardly from the consistency of Hn as an estimator of H0, and the
techniques (integration by parts) used in our proofs. Now, the third term on the right hand
side can be written as:
−
∫ ∫
b(z, s)f2(z, y, u, s;β)d(Hn −H0)(y, z)∫
f2(z, y, u, s;β)dH0(y, z)
E[dNX0(u, θ)dNY 0(s, η0)]+∫ ∫
b(z, s)f2(z, y, u, s;β)dHn(y, z)∫
f2(z, y, u, s;β)dHn(y, z)
∫
f2(z, y, u, s;β)dH0(y, z)
×∫
f2(z, y, u, s;β)d(Hn −H0)(y, z)E[dNX0(u, θ)dNY 0(s, η0)] (27)
To control the asymptotic behavior of the empirical process terms of the form
∫
fd(Hn−H)
in (6), we assume that F2 and Fb are uniformly bounded H0-Donsker classes (RC6). By
Example 2.10.8 of van der Vaart and Wellner (1996), we then know that Fb × F2 is also a
uniformly bounded H0-Donsker class. Let
F∗2 ≡ {(z, y)→ f ∗2 (z, y, u, s; β) = b(z, s)f2(z, y, u, s; β) : u, s, β}
Under the above conditions conditions, we then have that supf2∈F2 |
∫
f2d(Hn −H0) | and
supf∗2∈F∗2 |
∫
f ∗2d(Hn −H0) | are OP0(1/
√
n). To control the behavior of the denominator of
(6), we assume that, with probability 1,
I(δ = ξ = 1)
∫
f2(z, y, L˜(X, M˜(Y, Z; η), Z; θ), M˜(Y, Z; η); β)dH0(y, z) > δ
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for some δ > 0, uniformly in β ∈ β (RC6). It then follows by empirical process theory (van
der Vaart and Wellner, 1996) that (6) can be expressed as
−
∫ ∫
b(z, s)f2(z, y, u, s;β)d(Hn −H0)(y, z)∫
f2(z, y, u, s;β)dH0(y, z)
E[dNX0(u, θ)dNY 0(s, η0)]+∫ ∫
b(z, s)f2(z, y, u, s;β)dH0(y, z){∫
f2(z, y, u, s;β)dH0(y, z)
}2 ∫ f2(z, y, u, s;β)d(Hn −H0)(y, z)E[dNX0(u, θ)dNY 0(s, η0)]+
oP0(1/
√
n).
This proves the lemma.
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Captions
Table 1: Prognostic Baseline Factors, Stratified by Treatment Group
Table 2: Results of Simulation Studies
Table 3: Regression Estimates and Standard Errors (Subscripted) from Bivariate Linear
Regression Model Using SLR and PF.
Figure 1: The function r(t, w; η0a) represents the quantile-quantile mapping function between
these distributions of death.The distributions without [ ] are equal to the distributions with
brackets under randomization.
Figure 2: The function q(t, u, w; θ0a) represents the quantile-quantile mapping function be-
tween distributions of progression. The distributions without [ ] are equal to the adjacent
distributions with brackets under randomization and rank preservation
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Table 1:
Carmustime Placebo
Polymer Polymer
Prognostic Factor (n = 110) (n = 109)
Resection > 75 74.5% 73.4%
Age 48.1 47.3
White 90.9% 91.7%
Karnofsky > 70 55.5% 51.4%
Local Radiation 74.5% 79.8%
Previous Nitrosoureas 49.1% 44.0%
Active Tumor Histology 93.6% 90.8%
Glioblastoma Subtype 69.1% 66.1%
Anaplastic Astrocytoma Subtype 12.7% 13.8%
Oliodendroglioma Subtype 13.6% 17.4%
Other Subtype 4.5% 2.8%
Table 2:
(a) Bivariate Exponential
M.C. Avg. M.C. Cov.
Truth Avg. Est. S.E. S.D. Prob.
θ1 0.4 0.4005 0.3218 0.3048 94.3%
θ2 -0.1 -0.1014 0.1603 0.1541 95.9%
θ3 -0.2 -0.1928 0.3208 0.3110 94.8%
η1 0.2 0.1972 0.1540 0.1551 94.4%
η2 -0.3 -0.2990 0.0765 0.0753 94.0%
η3 -0.4 -0.4024 0.1525 0.1538 94.7%
(b) Bivariate Normal
M.C. Avg. M.C. Cov.
Truth Avg. Est. S.E. S.D. Prob.
θ1 0.4 0.3874 0.2371 0.2344 94.7%
θ2 -0.1 -0.0951 0.1173 0.1150 94.7%
θ3 -0.2 -0.2095 0.2345 0.2413 94.9%
η1 0.2 0.1992 0.1518 0.1516 94.4%
η2 -0.3 -0.2966 0.0741 0.0738 93.8%
η3 -0.4 -0.3963 0.1500 0.1475 94.8%
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Table 3:
Cerebellar Progression Death
Covariate SRL PF SLR/PF
Treatment 0.3770.155 0.3450.293 0.2800.111
Resection > 75 0.4460.181 0.3540.272 0.3390.130
Age (in decades) −0.2700.074 −0.2140.200 −0.1720.047
White −0.2120.281 −0.3970.319 −0.4210.206
Karnofsky > 70 0.0750.170 0.0640.330 0.2920.120
Local Radiation 0.4660.174 0.2440.402 0.3990.120
Previous Nitrosoureas −0.6060.176 −0.4440.367 −0.2740.121
Active Tumor Histology −0.1520.343 0.0300.291 −0.4580.283
Anaplastic Astrocytoma Subtype 1.0220.285 0.6060.409 0.4710.152
Oliodendroglioma Subtype 1.2040.323 1.1320.405 0.8390.230
Other Subtype 0.8990.590 0.8520.316 0.8160.276
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Figure 2:
3 4 5 6 7 8
0.
0
0.
2
0.
4
0.
6
0.
8
1.
0
Time
Pr
ob
ab
ilit
y
SX0(.|V=0,Y0=u,W=w) SX0(.|V=1,Y0=r−1(u,w;η0a),W=w)
[SX0(0)(.|Y0(0)=u,W=w)] [SX0(1)(.|Y0(0)=u,W=w)]
SX0(t|V=1,Y0=r−1(u,w;η0a),W=w)
[SX0(1)(.|Y0(0)=u,W=w)]
tq(t,u,w;θ0a)
44
http://biostats.bepress.com/jhubiostat/paper137
